Literature DB >> 236796

Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics.

J Hughes, H W Kosterlitz, F M Leslie.   

Abstract

1. Morphine inhibits the electrically evoked (0.1-0.15 Hz, 1 ms) contractions of the longitudinal muscle of the mouse vas deferens but not of the rabbit, guinea-pig, rat, cat, hamster or gerbil. This effect is stereospecific and is antagonized by naloxone or naltrexone. 2. Normorphine is equiactive with morphine but its effects are more rapid in onset and decline. 3. In the mouse vas deferens, the resting outflow of tritium-labelled catecholamines is unaffected by morphine. The electrically evoked outflow is depressed by morphine or normorphine in a dose-dependent manner. The ID50 for inhibition of contraction and for depression of outflow is 0.5 muM. 4. The relative agonist potencies of compounds without antagonist component (codeine, pethidine, morphine, normorphine, heroin, levorphanol, Ba-20227, etorphine) show good correlation with the relative agonist potencies determined in the guinea-pig ileum and for analgesia in man. 5. For compounds with dual agonist and antagonist properties, the dose-response curves for agonist activity are shallow. When the lowest concentrations giving a depression of the contraction of the mouse vas deferens are used, a good correlation is obtained with the guinea-pig ileum. 6. The relative antagonist potencies of naloxone, nalorphine, levallorphan, and cyclazocine agree well with those obtained in the guinea-pig ileum; these, in turn, correlate well with the values obtained in the morphine-dependent monkey. 7. The fact that the agonist effects of drugs with dual agonist and antagonist action show little or no dependence on concentration, makes the mouse vas deferens particularly suitable for the assay of assay of antagonist activity. 8. As an assay preparation, the mouse vas deferens is less robust and consistent in its responses than the guinea-pig ileum.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 236796      PMCID: PMC1666422          DOI: 10.1111/j.1476-5381.1975.tb07373.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Comparative potencies of codeine and its demethylated metabolites after intraventricular injection in the mouse.

Authors:  T K ADLER
Journal:  J Pharmacol Exp Ther       Date:  1963-05       Impact factor: 4.030

2.  HISTOCHEMICAL CORRELATIONS OF ACETYLCHOLINESTERASE AND CATECHOLAMINES IN POSTGANGLIONIC AUTONOMIC NERVES OF THE CAT, RABBIT, AND GUINEA PIG.

Authors:  D JACOBOWITZ; G B KOELLE
Journal:  J Pharmacol Exp Ther       Date:  1965-05       Impact factor: 4.030

3.  Abolition of neurally evoked motor responses of the vas deferens by 6-hydroxydopamine.

Authors:  R M Wadsworth
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

4.  A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens.

Authors:  G Henderson; J Hughes; H W Kosterlitz
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

5.  Assessment of the agonist and antagonist properties of narcotic analgesic drugs by their actions on the morphine receptor in the guinea pig ileum.

Authors:  H W Kosterlitz; A A Waterfield; V Berthoud
Journal:  Adv Biochem Psychopharmacol       Date:  1973

6.  Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum.

Authors:  E A Gyand; H W Kosterlitz
Journal:  Br J Pharmacol Chemother       Date:  1966-09

7.  Inhibition of noradrenaline release by lysergic acid diethylamide.

Authors:  J Hughes
Journal:  Br J Pharmacol       Date:  1973-12       Impact factor: 8.739

8.  Properties of opiate-receptor binding in rat brain.

Authors:  C B Pert; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

9.  Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium.

Authors:  M C Boadle-Biber; J Hughes; R H Roth
Journal:  Br J Pharmacol       Date:  1970-12       Impact factor: 8.739

10.  Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens.

Authors:  J Hughes
Journal:  Br J Pharmacol       Date:  1972-03       Impact factor: 8.739

View more
  66 in total

1.  Proceedings: Is morphine inhibition to the twitch response of the mouse vas deferens mediated via noradrenaline?

Authors:  D A Jenkins; I Marshall; P A Nasmyth
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration.

Authors:  A W Mudge; S E Leeman; G D Fischbach
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

3.  The effects of opioid drugs and of lithium on steroidogenesis in rat adrenal cell suspensions.

Authors:  A Gibson; M Ginsburg; M Hall; S L Hart
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

4.  Adrenocorticotrophic hormone fragments mimic the effect of morphine in vitro.

Authors:  G J Plomp; J M Van Ree
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

5.  Comparison of the receptor binding characteristics of opiate agonists interacting with mu- or kappa-receptors.

Authors:  H W Kosterlitz; F M Leslie
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

6.  Chromenopyrazoles: non-psychoactive and selective CB₁ cannabinoid agonists with peripheral antinociceptive properties.

Authors:  Jose Cumella; Laura Hernández-Folgado; Rocio Girón; Eva Sánchez; Paula Morales; Dow P Hurst; Maria Gómez-Cañas; Maria Gómez-Ruiz; Diana C G A Pinto; Pilar Goya; Patricia H Reggio; María Isabel Martin; Javier Fernández-Ruiz; Artur M S Silva; Nadine Jagerovic
Journal:  ChemMedChem       Date:  2012-02-02       Impact factor: 3.466

7.  Antibodies as a means of isolating and characterizing biologically active substances: presence of a non-peptide, morphine-like compound in the central nervous system.

Authors:  A R Gintzler; A Levy; S Spector
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

8.  An examination of the putative sigma-receptor in the mouse isolated vas deferens.

Authors:  C Kennedy; G Henderson
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

9.  Comparison of the cardiovascular effects of meptazinol and naloxone following haemorrhagic shock in rats and cats.

Authors:  E Chance; P M Paciorek; M H Todd; J F Waterfall
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

10.  Genotype dependent response of morphine and methionine-enkephalin on the electrically induced contractions of the mouse vas deferens.

Authors:  F Berti; F Bruno; C Omini; G Racagni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.